Published in AIDS Res Ther on June 08, 2007
The human fetal glial cell line SVG p12 contains infectious BK polyomavirus. J Virol (2014) 1.15
BK virus infection in human immunodeficiency virus-infected patients. Eur J Clin Microbiol Infect Dis (2011) 0.79
BK Virus Encephalitis in HIV-Infected Patients: Case Report and Review. Case Rep Med (2017) 0.75
BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency. Acta Neuropathol Commun (2016) 0.75
BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies. Clin Microbiol Rev (2017) 0.75
Human BK Polyomavirus-The Potential for Head and Neck Malignancy and Disease. Cancers (Basel) (2015) 0.75
The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol (2002) 3.10
Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol (2004) 3.06
Polyomavirus BK. Lancet Infect Dis (2003) 2.99
Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol (1989) 2.94
Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol (2003) 2.93
BK virus: opportunity makes a pathogen. Clin Infect Dis (2005) 1.90
JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol (2005) 1.79
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol (2005) 1.77
The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol (2003) 1.51
Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol (1993) 1.37
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature. J Neurovirol (2003) 1.23
JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.19
BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS (1999) 1.12
Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol (2006) 1.04
BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis. Infection (2003) 0.96
Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop (2006) 0.96
BK virus encephalitis in a patient with AIDS and lymphoma. AIDS (2001) 0.93
International NeuroAIDS: prospects of HIV-1 associated neurological complications. Cell Res (2005) 0.91
BK virus DNA in CSF of immunocompetent and immunocompromised patients. Arch Dis Child (2003) 0.84
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood (2002) 2.17
Postinfectious neurologic syndromes: a prospective cohort study. Neurology (2013) 1.73
Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst (2002) 1.69
Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis (2008) 1.65
Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjects. J Clin Virol (2009) 1.58
Aetiology and clinical presentation of pneumonia in hospitalized and outpatient children in Northeast Brazil and risk factors for severity. J Health Popul Nutr (2005) 1.58
JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls. J Neurovirol (2007) 1.56
JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: clinical presentations, associated factors with mortality and outcome. Braz J Infect Dis (2012) 1.45
First identification and molecular characterization of lymphotropic polyomavirus in peripheral blood from patients with leukoencephalopathies. J Clin Microbiol (2008) 1.28
JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy. J Cell Physiol (2012) 1.20
A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine. J Neurovirol (2005) 1.19
Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation. J Biol Chem (2011) 1.17
Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil. J Clin Microbiol (2007) 1.16
Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J Infect Dis (2007) 1.16
Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis. J Clin Microbiol (2006) 1.10
Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology (2008) 1.05
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma. J Med Virol (2008) 1.05
Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient. Neurol Sci (2008) 1.04
Cerebral infarction related to cryptococcal meningitis in an HIV-infected patient: case report and literature review. Braz J Infect Dis (2004) 1.02
Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America. Braz J Infect Dis (2013) 1.00
PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J Clin Microbiol (2004) 1.00
Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Arch Neurol (2005) 0.99
Seroprevalence of Kaposi sarcoma-associated herpesvirus and other serologic markers in the Brazilian Amazon. Emerg Infect Dis (2009) 0.99
Aids-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo (2008) 0.99
Presence, quantitation and characterization of JC virus in the urine of Italian immunocompetent subjects. J Med Virol (2007) 0.98
Cerebrospinal fluid miRNA profile in HIV-encephalitis. J Cell Physiol (2013) 0.98
Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDS (2005) 0.96
Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol (2003) 0.96
Cerebral aspergillosis due to Aspergillus fumigatus in AIDS patient: first culture-proven case reported in Brazil. Rev Inst Med Trop Sao Paulo (2005) 0.95
Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. J Gen Virol (2006) 0.94
Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol Aging (2006) 0.93
Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr (2004) 0.93
HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol (2004) 0.92
Mutations in the external loops of BK virus VP1 and urine viral load in renal transplant recipients. J Cell Physiol (2010) 0.92
Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering. J Med Virol (2005) 0.92
Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals. J Med Virol (2008) 0.91
Acute disseminated encephalomyelitis. Neurol Sci (2008) 0.90
Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol (2007) 0.89
Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy. Virology (2010) 0.89
Molecular analysis of JC virus genotypes circulating among the Italian healthy population. J Neurovirol (2003) 0.87
Longitudinal study of two cases of progressive multifocal leukoencephalopathy with a clinical benign evolution. J Neurovirol (2007) 0.87
Human leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14. J Neurooncol (2005) 0.86
Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis. J Neuroimmunol (2004) 0.86
JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy. J Neurovirol (2008) 0.86
Molecular characterization of Kaposi's sarcoma associated herpesvirus (KSHV) from patients with AIDS-associated Kaposi's sarcoma in Sao Paulo, Brazil. J Clin Virol (2005) 0.85
Polymorphisms of the BK virus subtypes and their influence on viral in vitro growth efficiency. Virus Res (2010) 0.85
Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis. J Med Virol (2010) 0.85
Immunospot assay based on fluorescent nanoparticles for Dengue fever detection. Biosens Bioelectron (2012) 0.84
Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy. Biomed Pharmacother (2007) 0.84
HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation. Oncogene (2004) 0.84
Utility of brain biopsy in patients with acquired immunodeficiency syndrome before and after introduction of highly active antiretroviral therapy. Neurosurgery (2008) 0.83
Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis (2012) 0.83
Interaction between serine phosphorylated IRS-1 and beta1-integrin affects the stability of neuronal processes. J Neurosci Res (2007) 0.83
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients. Mult Scler (2011) 0.83
Molecular characterisation of JC virus strains detected in human brain tumours. Pathology (2003) 0.82
Pathogenic mechanisms of meningitis/encephalitis caused by human herpesvirus-6 in immunocompetent adult patients. Clin Infect Dis (2005) 0.82
Thymic volume predicts long-term immune reconstitution in HIV-infected children treated with highly active antiretroviral therapy. AIDS (2002) 0.81
Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases. Clin Immunol (2008) 0.81
Review on the relationship between human polyomaviruses-associated tumors and host immune system. Clin Dev Immunol (2012) 0.81
Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1. J Dermatol Sci (2008) 0.81
Investigation of polyomaviruses replication in pediatric patients with nephropathy receiving rituximab. J Med Virol (2012) 0.81
Latent viral infections in young patients with inflammatory diseases treated with biological agents: prevalence of JC virus genotype 2. J Med Virol (2013) 0.81
Endothelin-1 production by a microvascular endothelial cell line treated with Plasmodium falciparum parasitized red blood cells. Clin Sci (Lond) (2002) 0.80
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. J Neurovirol (2012) 0.80
A review on JC virus infection in kidney transplant recipients. Clin Dev Immunol (2013) 0.80
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. J Neurovirol (2014) 0.79
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. J Neuroimmunol (2003) 0.79
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial. Antivir Ther (2004) 0.79
Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis. J Neuroimmunol (2005) 0.79
Detection of herpesvirus-6A in a case of subacute cerebellitis and myoclonic dystonia. J Med Virol (2005) 0.79
Growth hormone in T-lymphocyte thymic and postthymic development: a study in HIV-infected children. J Pediatr (2004) 0.79
Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality. Int J Infect Dis (2009) 0.79
Evidence supporting the association of polyomavirus BK genome with prostate cancer. Med Microbiol Immunol (2013) 0.79
The manifestation of AIDS in Africa: an epidemiological overview. J Neurovirol (2005) 0.79
A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder. Hum Immunol (2006) 0.78
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy. J Med Virol (2013) 0.78
Association study of the HLA-A2 allele in Italian Alzheimer disease patients. Neurobiol Aging (2008) 0.78
Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR. J Vis Exp (2014) 0.78
Transmission of human herpesvirus type 8 infection within families in american indigenous populations from the Brazilian Amazon. J Infect Dis (2012) 0.78
HLA-Cw allele frequencies in northern and southern Italy. Transpl Immunol (2007) 0.77
Ring enhancing intracranial lesion responding to antituberculous treatment in an HIV-infected patient. Rev Inst Med Trop Sao Paulo (2010) 0.77